18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies

NCT02348749 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Neuroendocrine Tumors

Interventions

RADIATION: 18F-MFBG (meta-fluoro benzylguanidine)
DEVICE: Positron emission tomography (PET) imaging
OTHER: Blood draws

Sponsor

Memorial Sloan Kettering Cancer Center